The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease

Journal of Thrombosis and Haemostasis

Volumn 6, Issue 1, 2008, Pages 90-96

  Stakiw, J ^a   Bowman, M ^a   Hegadorn, C ^a   Pruss, C ^a   Notley, C ^a   Groot, E ^b   Lenting, P J ^b   Rapson, D ^a   Lillicrap, D ^a   James, Paula ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Activated VWF; ADAMTS 13; Exercise; Von Willebrand disease

Indexed keywords

VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; BLEEDING; BLOOD ANALYSIS; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; MALE; MOLECULAR WEIGHT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; THROMBOCYTE COUNT; TREADMILL EXERCISE; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASE TYPE 1; VON WILLEBRAND DISEASE TYPE 2B;

ADAM PROTEINS; CASE-CONTROL STUDIES; EXERCISE; FACTOR VIII; HUMANS; PLATELET COUNT; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 37549033499     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02790.x     Document Type: Article

References (28)

1. Ruggeri ZM. The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces. Thromb Haemost 1995; 74: 460-3.
2. Fowler WE, Fretto LJ, Hamilton KK, Erickson HP, McKee PA. Substructure of human von Willebrand factor. J Clin Invest 1985; 76: 1491-500.
3. Montgomery RR, Gill JC. Interactions between von Willebrand factor and factor VIII: Where did they first meet. J Pediatr Hematol Oncol 2000; 22: 269-75.
4. Rosenberg JB, Greengard JS, Montgomery RR. Genetic induction of a releasable pool of factor VIII in human endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20: 2689-95.
5. Sadler JE. von Willebrand factor: Two sides of a coin. J Thromb Haemost 2005; 3: 1702-9.
6. Reiter RA, Knobl P, Varadi K, Turecek PL. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin. Blood 2003; 101: 946-8.
7. Reiter RA, Varadi K, Turecek PL, Jilma B, Knobl P. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost 2005; 93: 554-8.
8. Mannucci PM, Capoferri C, Canciani MT. Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease. Br J Haematol 2004; 126: 213-8.
9. Lenting PJ, Westein E, Terraube V, Ribba AS, Huizinga EG, Meyer D, de Groot PG, Denis CV. An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation. J Biol Chem 2004; 279: 12102-9.
10. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691.
11. Miller CH, Dilley A, Richardson L, Hooper WC, Evatt BL. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. Am J Hematol 2001; 67: 125-9.
12. Federici AB. Diagnosis of inherited von Willebrand disease: A clinical perspective. Semin Thromb Hemost 2006; 32: 555-65.
13. Wang JS, Chow SE, Chen JK. Strenuous, acute exercise affects reciprocal modulation of platelet and polymorphonuclear leukocyte activities under shear flow in men. J Thromb Haemost 2003; 1: 2031-7.
14. El-Sayed MS, Sale C, Jones PG, Chester M. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000; 32: 918-25.
15. Ribeiro J, Almeida-Dias A, Ascensao A, Magalhaes J, Oliveira AR, Carlson J, Mota J, Appell HJ, Duarte J. Hemostatic response to acute physical exercise in healthy adolescents. J Sci Med Sport 2007; 10: 164-9.
16. Rock G, Tittley P, Pipe A. Coagulation factor changes following endurance exercise. Clin J Sport Med 1997; 7: 94-9.
17. Claus RA, Bockmeyer CL, Sossdorf M, Losche W, Hilberg T. Physical stress as a model to study variations in ADAMTS-13 activity, von Willebrand factor level and platelet activation. J Thromb Haemost 2006; 4: 902-5.
18. Clinical and Laboratory Standards Institute (formerly NCCLS). Assays of Von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline. Wayne, PA: H51-A 22, Number 20. CLSI, 2002.
19. Hardisty RM, Macpherson JC. A one-stage factor VIII (antihaemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diath Haemorrh 1962; 7: 215-28.
20. Budde U, Schneppenheim R, Plendl H, Dent J, Ruggeri ZM, Zimmerman TS. Luminographic detection of von Willebrand factor multimers in agarose gels and on nitrocellulose membranes. Thromb Haemost 1990; 63: 312-5.
21. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980; 65: 1318-25.
22. Towbin H, Gordon J. Immunoblotting and dot immunobinding -current status and outlook. J Immunol Methods 1984; 72: 313-40.
23. Hulstein JJ, de Groot PG, Silence K, Veyradier A, Fijnheer R, Lenting PJ. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B. Blood 2005; 106: 3035-42.
24. Stibbe J. Effect of exercise on FVIII-complex: Proportional increase of ristocetin cofactor (von Willebrand factor) and FVIII-AGN, but disproportional increase of FVIII-AHF. Thromb Res 1977; 10: 163-8.
25. Small M, Tweddel AC, Rankin AC, Lowe GD, Prentice CR, Forbes CD. Blood coagulation and platelet function following maximal exercise: Effects of beta-adrenoceptor blockade. Haemostasis 1984; 14: 262-8.
26. Prentice CRM, Forbes CD, Smith SM. Rise of factor VIII after exercise and adrenaline infusion, measured by immunological and biological techniques. Thromb Res 1972; 1: 493-506.
27. Tokuue J, Hayashi J, Hata Y, Nakahara K, Ikeda Y. Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. Thromb Haemost 1996; 75: 833-7.
28. Mannucci PM. Treatment of von Willebrand's disease. N Engl J Med 2004; 351: 683-94.